2Isumoto,K,Ejima,D,Kumagai,I,Practical considerations in refolding proteins from inclusion bodies[J].Protein Expr Purif.2003,28:1~8
3Derman A I,Prinz W,Belin D et al.Mutations that allow disulfide bond formation in the cytosol of Escherichia coli[J].Sciene,1993,262:1744~1747
4Lili H,Schwarz E,Rudolph R.Advances in refolding of proteins produced in E.coli[J].Curr Opin Biotechnol,1998,9:497~501
5Patra A K,Mukhopadhyay et al.Optimization of inclusion body solubilization and renaturation of recombinant human growth hormong from Escherichia coli[J].Protein Expr Purif,2000,18:338~393
6Kiefer H,Maier K,Refolding of G-protein-coupled receptors from inclusion bodies produced in Escherichia coli[J].Biochem SocTrans,1999,27(6):903~911
7Panda,A K,Bioprocessing of the therapeutic proteins from the inclusion bodies of Escherichia coli[J].Adv Biochem Eng Biotechnol,2003,85:43~93
8Hevehan D L,Clark E D B.Oxidative renaturation of lysozyme at high concentration[J].Biotechnol Bioeng.
9Xie Y,Wetlaufer D B.Control of aggregation in protein folding:the temperature-leap tactic[J].Protein Sci,1996,5:517~523.
1SONG G (宋刚),YU M (于敏),SONG H Y (宋后燕) et al. R ati onal Design, Over-expression and Characterization of a Navel Staphylokinase wit h Lower Tendency of Polymerization. Engineering Science(中国工程科学),2000 ,2(11):68
2David R Phillips, Israel F Charo, Laurence A Fitzgerald et al. The platelet membrane glycoproteinⅡb-Ⅲa complex. Blood, 1998, 71(4):1
3Huang T F, Shen J R, Liu C S et al. Triflavin. an antiplatel et Arg-Gly-As p-containing peptide, is a specific antagonist of platelet membrane glycoprotei nⅡb/Ⅲa complex. J Biochem(Tokyo), 1991,109:328
4Walda B.van Zyl, Gert H J Pretorius, Harry F Kotze et al. Pr oduction of a r ecombinant antithrombotic and fibrinolytic protein, PLATSak, in Escherichia co li. Thrombosis reserch, 1997, 88: 419~426
5Batas B,Chaudhuri J B. Protein refolding at high concentration u sing size-exclusion chromatography. Biotechnol Bioengin, 1996,50:16~23
6Zhan C H, Liang D C, Song H Y et al. Crystallyzation and pre liminary X-ray diffraction studies of recombinant staphylokinase. Acta Cryst, 1996, 52:564~565
7Rabins A, De Bondt H L, De Ranter C. Three-dimensional-struct ure of staphylo kinase, a plasmingen activator with thrapeutical potential. Nat Struct Biol, 1997,4:357~360
8Ohlenschlager D, Ramachandran R, Brown LR. Nuclear magnetic res onance solut ion structure of the plasminogen-activator protein staphylokinase. Biochemist ry, 1998,37:10635~10642